Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Cancer Treatment Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 CAR-T Therapy
1.2.3 Targeted Cancer Therapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Next Generation Cancer Treatment Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Lung Cancer
1.3.3 Colorectal Cancer
1.3.4 Stomach Cancer
1.3.5 Breast Cancer
1.3.6 Liver Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Cancer Treatment Market Perspective (2024-2034)
2.2 Next Generation Cancer Treatment Growth Trends by Region
2.2.1 Global Next Generation Cancer Treatment Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Next Generation Cancer Treatment Historic Market Size by Region (2024-2024)
2.2.3 Next Generation Cancer Treatment Forecasted Market Size by Region (2024-2034)
2.3 Next Generation Cancer Treatment Market Dynamics
2.3.1 Next Generation Cancer Treatment Industry Trends
2.3.2 Next Generation Cancer Treatment Market Drivers
2.3.3 Next Generation Cancer Treatment Market Challenges
2.3.4 Next Generation Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Cancer Treatment Players by Revenue
3.1.1 Global Top Next Generation Cancer Treatment Players by Revenue (2024-2024)
3.1.2 Global Next Generation Cancer Treatment Revenue Market Share by Players (2024-2024)
3.2 Global Next Generation Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Cancer Treatment Revenue
3.4 Global Next Generation Cancer Treatment Market Concentration Ratio
3.4.1 Global Next Generation Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Cancer Treatment Revenue in 2022
3.5 Next Generation Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Next Generation Cancer Treatment Product Solution and Service
3.7 Date of Enter into Next Generation Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Cancer Treatment Breakdown Data by Type
4.1 Global Next Generation Cancer Treatment Historic Market Size by Type (2024-2024)
4.2 Global Next Generation Cancer Treatment Forecasted Market Size by Type (2024-2034)
5 Next Generation Cancer Treatment Breakdown Data by Application
5.1 Global Next Generation Cancer Treatment Historic Market Size by Application (2024-2024)
5.2 Global Next Generation Cancer Treatment Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Next Generation Cancer Treatment Market Size (2024-2034)
6.2 North America Next Generation Cancer Treatment Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Next Generation Cancer Treatment Market Size by Country (2024-2024)
6.4 North America Next Generation Cancer Treatment Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Cancer Treatment Market Size (2024-2034)
7.2 Europe Next Generation Cancer Treatment Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Next Generation Cancer Treatment Market Size by Country (2024-2024)
7.4 Europe Next Generation Cancer Treatment Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Cancer Treatment Market Size (2024-2034)
8.2 Asia-Pacific Next Generation Cancer Treatment Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Next Generation Cancer Treatment Market Size by Region (2024-2024)
8.4 Asia-Pacific Next Generation Cancer Treatment Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Cancer Treatment Market Size (2024-2034)
9.2 Latin America Next Generation Cancer Treatment Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Next Generation Cancer Treatment Market Size by Country (2024-2024)
9.4 Latin America Next Generation Cancer Treatment Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Cancer Treatment Market Size (2024-2034)
10.2 Middle East & Africa Next Generation Cancer Treatment Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Next Generation Cancer Treatment Market Size by Country (2024-2024)
10.4 Middle East & Africa Next Generation Cancer Treatment Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 OncoGenex Pharmaceuticals, Inc.
11.1.1 OncoGenex Pharmaceuticals, Inc. Company Detail
11.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview
11.1.3 OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Introduction
11.1.4 OncoGenex Pharmaceuticals, Inc. Revenue in Next Generation Cancer Treatment Business (2024-2024)
11.1.5 OncoGenex Pharmaceuticals, Inc. Recent Development
11.2 Cytokinetics Inc.
11.2.1 Cytokinetics Inc. Company Detail
11.2.2 Cytokinetics Inc. Business Overview
11.2.3 Cytokinetics Inc. Next Generation Cancer Treatment Introduction
11.2.4 Cytokinetics Inc. Revenue in Next Generation Cancer Treatment Business (2024-2024)
11.2.5 Cytokinetics Inc. Recent Development
11.3 Hospira Inc.
11.3.1 Hospira Inc. Company Detail
11.3.2 Hospira Inc. Business Overview
11.3.3 Hospira Inc. Next Generation Cancer Treatment Introduction
11.3.4 Hospira Inc. Revenue in Next Generation Cancer Treatment Business (2024-2024)
11.3.5 Hospira Inc. Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Detail
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Next Generation Cancer Treatment Introduction
11.4.4 GlaxoSmithKline plc Revenue in Next Generation Cancer Treatment Business (2024-2024)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Boehringer Ingelheim GmbH
11.5.1 Boehringer Ingelheim GmbH Company Detail
11.5.2 Boehringer Ingelheim GmbH Business Overview
11.5.3 Boehringer Ingelheim GmbH Next Generation Cancer Treatment Introduction
11.5.4 Boehringer Ingelheim GmbH Revenue in Next Generation Cancer Treatment Business (2024-2024)
11.5.5 Boehringer Ingelheim GmbH Recent Development
11.6 Bayer HealthCare AG
11.6.1 Bayer HealthCare AG Company Detail
11.6.2 Bayer HealthCare AG Business Overview
11.6.3 Bayer HealthCare AG Next Generation Cancer Treatment Introduction
11.6.4 Bayer HealthCare AG Revenue in Next Generation Cancer Treatment Business (2024-2024)
11.6.5 Bayer HealthCare AG Recent Development
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Detail
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Next Generation Cancer Treatment Introduction
11.7.4 Abbott Laboratories Revenue in Next Generation Cancer Treatment Business (2024-2024)
11.7.5 Abbott Laboratories Recent Development
11.8 Walking Fish Therapeutics
11.8.1 Walking Fish Therapeutics Company Detail
11.8.2 Walking Fish Therapeutics Business Overview
11.8.3 Walking Fish Therapeutics Next Generation Cancer Treatment Introduction
11.8.4 Walking Fish Therapeutics Revenue in Next Generation Cancer Treatment Business (2024-2024)
11.8.5 Walking Fish Therapeutics Recent Development
11.9 Kojin Therapeutics
11.9.1 Kojin Therapeutics Company Detail
11.9.2 Kojin Therapeutics Business Overview
11.9.3 Kojin Therapeutics Next Generation Cancer Treatment Introduction
11.9.4 Kojin Therapeutics Revenue in Next Generation Cancer Treatment Business (2024-2024)
11.9.5 Kojin Therapeutics Recent Development
11.10 Scorpion Therapeutics
11.10.1 Scorpion Therapeutics Company Detail
11.10.2 Scorpion Therapeutics Business Overview
11.10.3 Scorpion Therapeutics Next Generation Cancer Treatment Introduction
11.10.4 Scorpion Therapeutics Revenue in Next Generation Cancer Treatment Business (2024-2024)
11.10.5 Scorpion Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Next Generation Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of CAR-T Therapy
Table 3. Key Players of Targeted Cancer Therapy
Table 4. Key Players of Others
Table 5. Global Next Generation Cancer Treatment Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Next Generation Cancer Treatment Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 7. Global Next Generation Cancer Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 8. Global Next Generation Cancer Treatment Market Share by Region (2024-2024)
Table 9. Global Next Generation Cancer Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Next Generation Cancer Treatment Market Share by Region (2024-2034)
Table 11. Next Generation Cancer Treatment Market Trends
Table 12. Next Generation Cancer Treatment Market Drivers
Table 13. Next Generation Cancer Treatment Market Challenges
Table 14. Next Generation Cancer Treatment Market Restraints
Table 15. Global Next Generation Cancer Treatment Revenue by Players (2024-2024) & (US$ Million)
Table 16. Global Next Generation Cancer Treatment Market Share by Players (2024-2024)
Table 17. Global Top Next Generation Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Treatment as of 2022)
Table 18. Ranking of Global Top Next Generation Cancer Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Next Generation Cancer Treatment Revenue (CR5 and HHI) & (2024-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Next Generation Cancer Treatment Product Solution and Service
Table 22. Date of Enter into Next Generation Cancer Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Next Generation Cancer Treatment Market Size by Type (2024-2024) & (US$ Million)
Table 25. Global Next Generation Cancer Treatment Revenue Market Share by Type (2024-2024)
Table 26. Global Next Generation Cancer Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Next Generation Cancer Treatment Revenue Market Share by Type (2024-2034)
Table 28. Global Next Generation Cancer Treatment Market Size by Application (2024-2024) & (US$ Million)
Table 29. Global Next Generation Cancer Treatment Revenue Market Share by Application (2024-2024)
Table 30. Global Next Generation Cancer Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Next Generation Cancer Treatment Revenue Market Share by Application (2024-2034)
Table 32. North America Next Generation Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 33. North America Next Generation Cancer Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 34. North America Next Generation Cancer Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Next Generation Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 36. Europe Next Generation Cancer Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 37. Europe Next Generation Cancer Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Next Generation Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Asia-Pacific Next Generation Cancer Treatment Market Size by Region (2024-2024) & (US$ Million)
Table 40. Asia-Pacific Next Generation Cancer Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Next Generation Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 42. Latin America Next Generation Cancer Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 43. Latin America Next Generation Cancer Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Next Generation Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 45. Middle East & Africa Next Generation Cancer Treatment Market Size by Country (2024-2024) & (US$ Million)
Table 46. Middle East & Africa Next Generation Cancer Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 47. OncoGenex Pharmaceuticals, Inc. Company Detail
Table 48. OncoGenex Pharmaceuticals, Inc. Business Overview
Table 49. OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Product
Table 50. OncoGenex Pharmaceuticals, Inc. Revenue in Next Generation Cancer Treatment Business (2024-2024) & (US$ Million)
Table 51. OncoGenex Pharmaceuticals, Inc. Recent Development
Table 52. Cytokinetics Inc. Company Detail
Table 53. Cytokinetics Inc. Business Overview
Table 54. Cytokinetics Inc. Next Generation Cancer Treatment Product
Table 55. Cytokinetics Inc. Revenue in Next Generation Cancer Treatment Business (2024-2024) & (US$ Million)
Table 56. Cytokinetics Inc. Recent Development
Table 57. Hospira Inc. Company Detail
Table 58. Hospira Inc. Business Overview
Table 59. Hospira Inc. Next Generation Cancer Treatment Product
Table 60. Hospira Inc. Revenue in Next Generation Cancer Treatment Business (2024-2024) & (US$ Million)
Table 61. Hospira Inc. Recent Development
Table 62. GlaxoSmithKline plc Company Detail
Table 63. GlaxoSmithKline plc Business Overview
Table 64. GlaxoSmithKline plc Next Generation Cancer Treatment Product
Table 65. GlaxoSmithKline plc Revenue in Next Generation Cancer Treatment Business (2024-2024) & (US$ Million)
Table 66. GlaxoSmithKline plc Recent Development
Table 67. Boehringer Ingelheim GmbH Company Detail
Table 68. Boehringer Ingelheim GmbH Business Overview
Table 69. Boehringer Ingelheim GmbH Next Generation Cancer Treatment Product
Table 70. Boehringer Ingelheim GmbH Revenue in Next Generation Cancer Treatment Business (2024-2024) & (US$ Million)
Table 71. Boehringer Ingelheim GmbH Recent Development
Table 72. Bayer HealthCare AG Company Detail
Table 73. Bayer HealthCare AG Business Overview
Table 74. Bayer HealthCare AG Next Generation Cancer Treatment Product
Table 75. Bayer HealthCare AG Revenue in Next Generation Cancer Treatment Business (2024-2024) & (US$ Million)
Table 76. Bayer HealthCare AG Recent Development
Table 77. Abbott Laboratories Company Detail
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Next Generation Cancer Treatment Product
Table 80. Abbott Laboratories Revenue in Next Generation Cancer Treatment Business (2024-2024) & (US$ Million)
Table 81. Abbott Laboratories Recent Development
Table 82. Walking Fish Therapeutics Company Detail
Table 83. Walking Fish Therapeutics Business Overview
Table 84. Walking Fish Therapeutics Next Generation Cancer Treatment Product
Table 85. Walking Fish Therapeutics Revenue in Next Generation Cancer Treatment Business (2024-2024) & (US$ Million)
Table 86. Walking Fish Therapeutics Recent Development
Table 87. Kojin Therapeutics Company Detail
Table 88. Kojin Therapeutics Business Overview
Table 89. Kojin Therapeutics Next Generation Cancer Treatment Product
Table 90. Kojin Therapeutics Revenue in Next Generation Cancer Treatment Business (2024-2024) & (US$ Million)
Table 91. Kojin Therapeutics Recent Development
Table 92. Scorpion Therapeutics Company Detail
Table 93. Scorpion Therapeutics Business Overview
Table 94. Scorpion Therapeutics Next Generation Cancer Treatment Product
Table 95. Scorpion Therapeutics Revenue in Next Generation Cancer Treatment Business (2024-2024) & (US$ Million)
Table 96. Scorpion Therapeutics Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Next Generation Cancer Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Next Generation Cancer Treatment Market Share by Type: 2022 VS 2034
Figure 3. CAR-T Therapy Features
Figure 4. Targeted Cancer Therapy Features
Figure 5. Others Features
Figure 6. Global Next Generation Cancer Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Next Generation Cancer Treatment Market Share by Application: 2022 VS 2034
Figure 8. Lung Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Stomach Cancer Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Liver Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Next Generation Cancer Treatment Report Years Considered
Figure 15. Global Next Generation Cancer Treatment Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 16. Global Next Generation Cancer Treatment Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 17. Global Next Generation Cancer Treatment Market Share by Region: 2022 VS 2034
Figure 18. Global Next Generation Cancer Treatment Market Share by Players in 2022
Figure 19. Global Top Next Generation Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Cancer Treatment as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Next Generation Cancer Treatment Revenue in 2022
Figure 21. North America Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. North America Next Generation Cancer Treatment Market Share by Country (2024-2034)
Figure 23. United States Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Canada Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. Europe Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. Europe Next Generation Cancer Treatment Market Share by Country (2024-2034)
Figure 27. Germany Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. France Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. U.K. Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Italy Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Russia Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Nordic Countries Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Asia-Pacific Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Asia-Pacific Next Generation Cancer Treatment Market Share by Region (2024-2034)
Figure 35. China Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Japan Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. South Korea Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Southeast Asia Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. India Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Australia Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Latin America Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Latin America Next Generation Cancer Treatment Market Share by Country (2024-2034)
Figure 43. Mexico Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Brazil Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Middle East & Africa Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Middle East & Africa Next Generation Cancer Treatment Market Share by Country (2024-2034)
Figure 47. Turkey Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 48. Saudi Arabia Next Generation Cancer Treatment Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 49. OncoGenex Pharmaceuticals, Inc. Revenue Growth Rate in Next Generation Cancer Treatment Business (2024-2024)
Figure 50. Cytokinetics Inc. Revenue Growth Rate in Next Generation Cancer Treatment Business (2024-2024)
Figure 51. Hospira Inc. Revenue Growth Rate in Next Generation Cancer Treatment Business (2024-2024)
Figure 52. GlaxoSmithKline plc Revenue Growth Rate in Next Generation Cancer Treatment Business (2024-2024)
Figure 53. Boehringer Ingelheim GmbH Revenue Growth Rate in Next Generation Cancer Treatment Business (2024-2024)
Figure 54. Bayer HealthCare AG Revenue Growth Rate in Next Generation Cancer Treatment Business (2024-2024)
Figure 55. Abbott Laboratories Revenue Growth Rate in Next Generation Cancer Treatment Business (2024-2024)
Figure 56. Walking Fish Therapeutics Revenue Growth Rate in Next Generation Cancer Treatment Business (2024-2024)
Figure 57. Kojin Therapeutics Revenue Growth Rate in Next Generation Cancer Treatment Business (2024-2024)
Figure 58. Scorpion Therapeutics Revenue Growth Rate in Next Generation Cancer Treatment Business (2024-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed